Email Updates

Search form

You are here


To save lives, HIV treatment alone isn’t enough. Suppressing HIV is what matters.

In 2011, a landmark clinical trial showed that early initiation of anti-retroviral therapy (ART) for people who are HIV-infected cuts the risk of HIV transmission by a stunning 96 percent. The trial provided powerful new momentum to global efforts to expand treatment access — both for the health of individuals living with HIV and for the potential to prevent millions of new infections.

Getting people onto treatment, though, is only half the story. To save lives and slow the HIV epidemic, treatment needs to achieve long-term virologic suppression — meaning the level of HIV in a person’s body is essentially undetectable. In most countries, only a minority of people with HIV have their virus in check. To make viral suppression the norm, better adherence programs, viral load monitoring and other steps are urgently needed.

What We're Reading

HIV research has made two huge leaps, a groundbreaking vaccine trial and a team of researchers who have figured out how the virus hides in our bodies.

July 11, 2018

"Miami is the epicenter of the epicenter of HIV/AIDS in the United States," says Mario Stevenson, a virologist with a thick Scottish brogue who heads the infectious disease department at the University of Miami (UM) Miller School of Medicine, which shares a campus with Jackson Memorial. "There's no abatement in our upward slope."

June 13, 2018

People with HIV whose viral load has been fully suppressed for at least two years have a significantly lower risk of developing any form of cancer than other people with HIV, but still retain a higher risk of developing cancer than HIV-negative people of a similar age, a study of US military veterans published in Annals of Internal Medicine shows.

June 15, 2018
Subscribe to RSS - Treatment